(Photo by Pixabay from Pexels)

OXFORD, United Kingdom — Elephants could hold the key to curing cancer, new research reveals. Researchers from the University of Oxford say these giant mammals carry an army of tumor-fighting proteins that destroy mutated cells.

The discovery explains why Earth’s largest land animals are over five times less likely to develop the disease than humans. Harnessing the genes could lead to a “one-size-fits-all” therapy for one of the world’s deadliest diseases.

“This intricate and intriguing study demonstrates how much more there is to elephants than impressive size and how important it is that we not only conserve but also study these signature animals in minute detail. After all, their genetics and physiology are all driven by evolutionary history as well as today’s ecology, diet and behavior,” says study co-author Professor Fritz Vollrath in a university release.

Elephants exhibit high resistance to cancer, with mortality rates of less than five percent, compared to up to 25 percent among people. The phenomenon has puzzled biologists for decades, since larger creatures should be at greater risk.

Elephants carry more genome ‘guardians’

Cells keep dividing throughout an organism’s life, each carrying the risk of producing a tumor. However, elephants inherit 40 versions of a gene called p53, 20 from each parent. Scientists call them the “guardian of the genome.” They hunt down and kill cells with faulty DNA. All other mammals only have two versions of the gene.

Biochemical analysis and computer simulations also showed the 40 versions all have slight structural differences. This provides a much wider range of anti-cancer activity than our paltry two genes have — one from each parent.

“This is an exciting development for our understanding of how p53 contributes to preventing cancer development,” says co-author Professor Robin Fåhraeus from the French National Institute of Health and Medical Research.

“In humans, the same p53 protein is responsible for deciding if cells should stop proliferating or go into apoptosis but how p53 makes this decision has been difficult to elucidate. The existence of several p53 isoforms in elephants with different capacities to interact with MDM2 offers an exciting new approach to shed new light on p53’s tumor suppressor activity.”

The findings, published in the journal Molecular Biology and Evolution, also provide new insight into how the body activates p53 proteins.

The study opens the door to developing medications that increase p53’s sensitivity and response against cancer causing environments.

“Conceptually, the accumulation of structurally modified p53 pools, collectively or synergistically co-regulating the responses to diverse stresses in the cell, establishes an alternative mechanistic model of cell regulation of high potential significance to biomedical applications,” concludes Dr. Konstantinos Karakostis from the Autonomous University of Barcelona.

Elephants, prized for their ivory tusks, are critically endangered after being driven to the brink of extinction by poachers. Populations have experienced significant declines over the last century. There are now only about 400,000 left in Africa, and an estimated 30,000 in Asia. A century ago, they were common across both continents. Elephants also face add threats from habitat loss and global warming.

South West News Service writer Mark Waghorn contributed to this report.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink


Chris Melore


Sophia Naughton

Associate Editor


  1. joanofark06 says:

    Either I overlooked it, or it wasn’t mentioned in the article, but I really am curious to know, how would this cancer protein be collected or extracted from elephants. I’ve been knowing for a very long time now, that the killing of many elephants, from so many evil men, who just kill for their tusks, has about brought these wonderful animals to extinction, and therefore seeing this article, and wondering, would this thing they want from elephants, have men getting it from live elephant, in their natural environment, or would many elephants be rounded up, and set in cages, pens, etc, to collect from them, there, which that option would break my heart! OR the last and again heartbreaking option, be done. Round them up, and kill them all, as this so called protein, is needed?? I hope I can get a knowledgeable person to answer!

    1. SuzanneL says:

      They will just clone the proteins.

      1. Ty says:

        Elephants have up to 19 copy number variants “CNV” of TP53 genes. We all have p53 proteins, from TP53 genes. If the TP53 gene is mutated like it is in 50% of cancer, then up regulation of TP53 by down regulation of MDM2 with Beets may not be very effective.

  2. Gerald says:

    Evolution has had nothing to do with making the elephant what it is. Natural Selection did. But this is not evolution. The reasons why elephants are elephants us because their DNA was designed to make them as they are. And that same “armory” of defenses that protect them from cancer, also assures that their DNA could mot over time reproduce descendants that would need to classified differently from the original parent organisms.

  3. Pure blooded says:

    The vaxx will change the human DNA through mRNA.

  4. SuzanneL says:

    Sure, take the cure, but then your nose will grow down to the floor.

  5. David Boettger says:

    Actually… the discovery that elephants have multiple copies of p53 , accounting for their exceedingly low cancer rate of death(“elephants never die if cancer) despite their huge body mass and sheer astronomical number of cells which could theoretically mutate, was made about 10 years ago by geneticists at Primary Children’s Medical Center and at the University of Utah medical school, and was highlighted in a highly read article in Newsweek at the time. A geneticist took his kids to the Salt Lake City zoo and he asked the keeper what kinds of cancers do elephants get? The response… “elephants never get cancer.” Astonished, he made arrangements to return to draw a blood sample to analyze for the p53 gene, already understood to be an important cancer surveillance gene, humans having inky 2 copies. Thus, the discovery was made. The current cited study builds on that foundation by elucidating more of the details about how the protein coded by p53 works to prevent cancer. Resulting from the studies, PCMC developed a working partnership with WBBB Circus to conduct ongoing research and support for their elephant stock which continued until the woketard animal “rights” crowd shut down the circus. One more examples of liberals ruining everything they touch. Sorry to get political, but it’s the truth.
    David Boettger MD Pediatrics
    Salt Lake City UT

  6. CK says:

    I have Multiple Myeloma with deletion of TP53. I wonder if there is new hope for those of us with this complication.